Market Research

The Global  interventional neurology market  is expected to grow at an approximate CAGR of 7.8% during forecast period. Increasing participation of market players is the key factor driving the interventional neurology market. For instance, in 2018, Rapid Medical announced CE Mark approval in the European Union for its Tigertriever 13 stent retriever for the treatment of ischemic stroke. Various other factors such as technological advancements, presence of a large target patient population, favorable medical reimbursements and growing demand for effective neurovascular devices are also expected to propel the growth of the market. However, lack of skilled neurosurgeons and stringent regulations can hinder the market growth over the forecast period. Neurointerventional Radiology , or Neuro IR, is a subspecialty of the UCSF Department of Radiology where world-renowned physicians develop and perfect new techniques to treat stroke, brain tumors, cerebral aneurysms and other life thr...

The Global  medication management market  is expected to grow at an approximate CAGR of 13.4% during forecast period. Improvement in medication management workflow of hospitals is the key factor driving the medication management market. For instance, in 2015, Hospital Israelita Albert Einstein (HIAE) enterede an agreement with Swisslog Healthcare Solutions for material transport and medication management to re-engineer its pharmacy processes. Various other factors such as increasing number of healthcare organizations across the globe, advancement in medical technology, and global adoption of IT in the healthcare sector are also boosting the market growth. However, high software implementation and service maintenance costs restraints the market growth during the forecast period. Segmentation The Global medication management market is segmented based on systems, services, mode of delivery, end user and region. The global market for  medication management systems  is se...

Animal Health Industry Overview : Information by Animal Type (Farm Animal, Companion Animal), by Product (Pharmaceuticals, Vaccines, Feed Additives), Route of Administration (Oral, Parenteral, Topical), Distribution Channel (Veterinary Hospitals & Clinics, Retail, E-Commerce), and by Region (North America, Europe, Asia-Pacific, Middle East, and Africa) The global animal health market is expected to reach a market value of USD 61,297.76 million by 2027. The  animal health market  is expected to register a CAGR of 7.64% during the forecast period 2021-2027, to reach USD 61,297.76 million by 2027. MRFR recognizes the following companies as the key players in the global animal health market— Merck & Co., Inc. (US), Boehringer Ingelheim International GmbH (Germany), Chanelle Pharma (Ireland), Ceva (France), Nutreco N.V. (Netherlands), Vetoquinol SA (France), Virbac Group (France), Zoetis Inc. (US), Heska Corporation (US), and Elanco (US) among others. Market Highlights Anim...

The Global  Clinical Laboratory Services Market  is Expected to Showcase Exponential Growth Over the Forecast Period, owing to influential factors such as the rising healthcare expenditure globally, and the growing awareness about advanced global clinical laboratory services. The increased occurrence of chronic and infectious diseases such as diabetes, cancer, cardiovascular disorders, liver & kidney disorders, blood disorders, among others, have risen the global demand for improved diagnostics for the early disease detection. According to a report published by Market Research Future (MRFR), the Global Clinical Laboratory Services Market has been assessed to reach a valuation of more than USD 274,400 million at a substantial CAGR by the end of the forecast period. A clinical laboratory, also called medical laboratory, is a healthcare facility in which a wide range of laboratory procedures are carried out on clinical specimens to obtain exact details about the hea...

Global  Bone Growth Stimulator Market  held a market value of USD 1,213 million in 2017 and is projected to grow at a CAGR of 5.86% over the forecast period. Bone Growth Stimulators are devices that are used to boost the healing process during the treatment of the ailments such as spinal fixation, orthopedic fixation, bone fractures and many other. Bone Growth Stimulator enhances the healing process by stimulating the production of new cells, which will allow your fracture to heal considerably faster. This is a perfect approach when you want to get back on your feet quickly. Besides that, one major advantage is surgical operation can be prevented when this approach is used during treatment. Bone growth stimulators have revolutionized the treatment of bone fractures and spinal fusions and are becoming an important tool in the healing process. All these factors contribute to the growth of the bone growth stimulator market. Regional Analysis: Geographically, the Americas is antic...

Global  Coronary Stents Market  held a market value of USD 9,382.63 million in 2017 and is projected to grow at a CAGR of 7.81% over the forecast period. Coronary stents are used in the process of angioplasty to make the cross-section of the blood vessel wider. Stents hold the walls of the vessel and thus do not let it sag or shrink, thereby curing the blockages in the vessel. Coronary stents have revolutionized the practice of interventional cardiology by reducing early complications such as abrupt vessel closure and improving late clinical outcome (restenosis). This results in patient and physician satisfaction. Thus, this factor contributes heavily to the growth of this market. Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/6938 Regional Analysis: Geographically, the Americas is anticipated to dominate the global coronary stents market owing to the rising prevalence of the cardiovascular diseases such as cardiac arrhythmia, arterial b...

The global  biologics safety testing market  valued of USD 2.79 billion in the year 2017 and is expected to register a CAGR of 13.6% during the forecast period. Biologics safety testing is required for all biopharmaceutical products and vaccines to ensure the product is safe and free of contaminants. Growing pharmaceutical and biotech industry and increasing demand for biological products are expected to drive the growth of the market. However, stringent government regulations for the approval of biosimilars and high cost of drug development are likely to hamper the market growth over the forecast period. Regional Analysis: Geographically, the Americas is expected to dominate the global market owing to the presence of well-established players and rising demand for biological products. Europe is expected to hold the second largest position in the global market owing to the growing pharma and biotech industry. Asia-Pacific is expected to be the fastest growing market owing to th...

As predicted by the report furnished by Market Research Future (MRFR), the global  multiple myeloma treatment market  will be rising steadily at a lucrative CAGR of 11.0% during the forecast period. As per Multiple Myeloma Research Foundation, multiple myeloma generally occurs in bone marrow particularly located in the pelvic bones, spine, ribs, and the area of the hips and shoulders. Apart from this, the groups of myeloma cells prompt other cells present in the bone marrow to get rid of the solid part of the bone, causing osteolytic lesions or soft spots in the bone. This results in weakened bones as well as increasing the risk of fractures. Growing awareness regarding early cancer diagnosis along with the availability of advanced diagnostic techniques like imaging devices and personalized diagnostic tests are expected to provide lucrative growth opportunities for market expansion. The recent launch of monoclonal antibodies (mAbs) Empliciti and daratumumab coupled with effect...

The global  apoptosis assays market  held a market value of USD 2.99 billion in 2017 and is expected to register a CAGR of 9.4% during the forecast period. Increasing R&D expenses and growing cell-based research are expected to drive the growth of the market. On the other hand, required high investment for research activities can restrain the market growth over the assessment period. Recently, in 2016, the UCLA Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research and the Stein Eye Institute received USD 5.1 million from the California Institute for Regenerative Medicine. This funding helps for the development of novel therapy for blinding retinal conditions. Furthermore, the National Institutes of Health (NIH) invested USD 1.65 billion for stem cell research in 2017. This funding drives the growth of the apoptosis assays market. Regional Analysis: Geographically, the Americas is expected to dominate the global market owing to the presence of well-est...

Leukapheresis procedure   in which white blood cells (WBCs) are separated from a sample of blood. Leukapheresis is majorly carried out for chronic lymphocytic leukemia. It is anticipated that the market held a market value of USD 19.2 million in 2017 and is projected to grow at a CAGR of 7.7% over the forecast period. Currently, many companies are operating in the global  leukapheresis products market . The prominent players in the market are engaged in strategic collaborations, acquisitions, regional expansion, and new product launches to strengthen their market position. For instance, in February 2018, Terumo BCT entered into collaboration with Stafa Cellular Therapy. With this collaboration, Terumo BCT will act as a distributor for Stafa Cellular Therapy and will expand its access to StafaCT software to healthcare organizations.  The factors such as increasing number of blood donations, rising prevalence of leukemia, and demand for leukapheresis products in clinical re...

The global market for dental sterilization is getting a nod from several quarters and is slated to reach USD 1.5 billion during the forecast period with a 6.9% CAGR, Market Research Future (MRFR), in a recently revealed, research report, discussed factors that can impact the global  dental sterilization market  and ensure growth. The rising prevalence of dental diseases is triggering global growth. In the US, around 90% of students show some kind of tooth-related problems. This is also getting bolstered by dietary changes that are affecting the tooth. For instance, the consumption of sugar-rich or starch-rich food is also affecting dental health owing to which the market can register better growth. It is also getting support from hospitals and other dental departments.  Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/6659 Segmentation: The global report with a detailed understanding of the dental sterilization market, has been segmen...

Market Research Future (MRFR) perceives the growth of the global  care management solutions market  to be healthy and reach a significant valuation over the coming years. Care management comprises a set of activities aimed at improving patient care and assisting healthcare professionals in managing health conditions better. Care management solutions are deployed to enhance the experience of care, improve the health of populations and to reduce per capita costs of healthcare. With care management solutions, various processes can be automated such as adding patients to healthcare programs, sending reminders, scheduling appointments, assigning patients to care teams. In addition, care management solutions facilitate streamlining of processes of different healthcare departments. Request Free Sample Copy at:  https://www.marketresearchfuture.com/sample_request/6523 The global care management solutions market has been expanding on account of the high adoption of care management...

Structural heart diseases   are problems associated with the valves or tissues of the heart. These diseases may be congenital or might be acquired later in life. Structural heart diseases include cardiomyopathy, myocarditis, aortic valve stenosis, heart valve disease, atrial septal defect, mitral valve regurgitation, and others. As per the latest report of Market Research Future (MRFR), the structural heart devices market is poised to expand at CAGR of 10.4% over the forecast period. The  structural heart devices market  is primarily driven by a radical rise in the incidence rate of non-coronary heart disorders, increased demand for minimally invasive surgical procedures, and improving reimbursement schemes. In the past few years, tremendous advances have been achieved with respect to the understanding of these diseases, and accordingly, therapeutic modalities have been developed. A number of clinical trials and technology developments are underway, which is likely to pro...